Literature DB >> 17497078

Quantifying the A1AR distribution in peritumoural zones around experimental F98 and C6 rat brain tumours.

Markus Dehnhardt1, Christoph Palm, Andrea Vieten, Andreas Bauer, Uwe Pietrzyk.   

Abstract

Quantification of growth in experimental F98 and C6 rat brain tumours was performed on 51 rat brains, 17 of which have been further assessed by 3D tumour reconstruction. Brains were cryosliced and radio-labelled with a ligand of the peripheral type benzodiazepine-receptor (pBR), (3)H-Pk11195 [(1-(2-chlorophenyl)-N-methyl-N-(1-methyl-propylene)-3-isoquinoline-carboxamide)] by receptor autoradiography. Manually segmented and automatically registered tumours have been 3D-reconstructed for volumetric comparison on the basis of (3)H-Pk11195-based tumour recognition. Furthermore automatically computed areas of -300 microm inner (marginal) zone as well as 300 microm and 600 microm outer tumour space were quantified. These three different regions were transferred onto other adjacent slices that had been labelled by receptor autoradiography with the A(1) Adenosine receptor (A(1)AR)-ligand (3)H-CPFPX ((3)H-8-cyclopentyl-3-(3-fluorpropyl)-1-propylxanthine) for quantitative assessment of A(1)AR in the three different tumour zones. Hence, a method is described for quantifying various receptor protein systems in the tumour as well as in the marginal invasive zones around experimentally implanted rat brain tumours and their representation in the tumour microenvironment as well as in 3D space. Furthermore, a tool for automatically reading out radio-labelled rat brain slices from auto radiographic films was developed, reconstructed into a consistent 3D-tumour model and the zones around the tumour were visualized. A(1)AR expression was found to depend upon the tumour volume in C6 animals, but is independent on the time of tumour development. In F98 animals, a significant increase in A(1)AR receptor protein was found in the Peritumoural zone as a function of time of tumour development and tumour volume.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17497078     DOI: 10.1007/s11060-007-9391-6

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.506


  37 in total

Review 1.  Targeting the endocannabinoid system in cancer therapy: a call for further research.

Authors:  Maurizio Bifulco; Vincenzo Di Marzo
Journal:  Nat Med       Date:  2002-06       Impact factor: 53.440

Review 2.  Receptors for purines and pyrimidines.

Authors:  V Ralevic; G Burnstock
Journal:  Pharmacol Rev       Date:  1998-09       Impact factor: 25.468

Review 3.  Anti-angiogenic treatment strategies for malignant brain tumors.

Authors:  M Kirsch; G Schackert; P M Black
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

4.  CD24 promotes invasion of glioma cells in vivo.

Authors:  V Senner; A Sturm; I Baur; U H Schrell; L Distel; W Paulus
Journal:  J Neuropathol Exp Neurol       Date:  1999-08       Impact factor: 3.685

5.  Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts.

Authors:  Z M Bhujwalla; D Artemov; K Natarajan; E Ackerstaff; M Solaiyappan
Journal:  Neoplasia       Date:  2001 Mar-Apr       Impact factor: 5.715

6.  Overexpression of copper zinc superoxide dismutase suppresses human glioma cell growth.

Authors:  Ying Zhang; Weiling Zhao; Hannah J Zhang; Frederick E Domann; Larry W Oberley
Journal:  Cancer Res       Date:  2002-02-15       Impact factor: 12.701

7.  Localization of CD44 at the invasive margin of glioblastomas by immunoelectron microscopy.

Authors:  S Khoshyomn; P L Penar; M P Wadsworth; D J Taatjes
Journal:  Ultrastruct Pathol       Date:  1997 Nov-Dec       Impact factor: 1.094

8.  In vitro expression of MMP-2 and MMP-9 in glioma cells following exposure to inflammatory mediators.

Authors:  P O Esteve; P Tremblay; M Houde; Y St-Pierre; R Mandeville
Journal:  Biochim Biophys Acta       Date:  1998-05-27

9.  Differentiated rat glial cell strain in tissue culture.

Authors:  P Benda; J Lightbody; G Sato; L Levine; W Sweet
Journal:  Science       Date:  1968-07-26       Impact factor: 47.728

10.  Quantitative immunohistological analysis of the microvasculature in untreated human glioblastoma multiforme. Computer-assisted image analysis of whole-tumor sections.

Authors:  P Wesseling; J A van der Laak; H de Leeuw; D J Ruiter; P C Burger
Journal:  J Neurosurg       Date:  1994-12       Impact factor: 5.115

View more
  5 in total

Review 1.  Purinergic signalling and cancer.

Authors:  Geoffrey Burnstock; Francesco Di Virgilio
Journal:  Purinergic Signal       Date:  2013-12       Impact factor: 3.765

2.  Overexpression of ADK in human astrocytic tumors and peritumoral tissue is related to tumor-associated epilepsy.

Authors:  Marjolein de Groot; Anand Iyer; Emanuele Zurolo; Jasper Anink; Jan J Heimans; Detlev Boison; Jaap C Reijneveld; Eleonora Aronica
Journal:  Epilepsia       Date:  2011-11-16       Impact factor: 5.864

Review 3.  Glial adenosine kinase--a neuropathological marker of the epileptic brain.

Authors:  Eleonora Aronica; Ursula S Sandau; Anand Iyer; Detlev Boison
Journal:  Neurochem Int       Date:  2013-02-04       Impact factor: 3.921

4.  Differential Expression of Adenosine P1 Receptor ADORA1 and ADORA2A Associated with Glioma Development and Tumor-Associated Epilepsy.

Authors:  Jun Huang; Ming-Na Chen; Juan Du; Hao Liu; Yu-Jiao He; Guo-Liang Li; Shu-Yu Li; Wei-Ping Liu; Xiao-Yan Long
Journal:  Neurochem Res       Date:  2016-04-02       Impact factor: 3.996

5.  Paris saponin H inhibits the proliferation of glioma cells through the A1 and A3 adenosine receptor‑mediated pathway.

Authors:  Linlin Bi; Yang Liu; Qian Yang; Xuanxuan Zhou; Hua Li; Yang Liu; Jie Li; Yunyang Lu; Haifeng Tang
Journal:  Int J Mol Med       Date:  2021-02-04       Impact factor: 4.101

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.